1.
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
by Gæde, Peter
Diabetologia, 2016, Vol.59 (11), p.2298-2307
2.
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
by Palmer, Suetonia C, PhD
The Lancet (British edition), 2015, Vol.385 (9982), p.2047-2056
3.
A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes
by Asche, Carl
Clinical therapeutics, 2011, Vol.33 (1), p.74-109
4.
Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997–2011
by Huo, Lili
Diabetologia, 2018, Vol.61 (5), p.1055-1063
5.
Diabetes Complications Severity Index (DCSI) – Update and ICD-10 Translation
by Glasheen, William P
Journal of diabetes and its complications, 2017, Vol.31 (6), p.1007-1013
6.
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised...
by Griffin, Simon J, Dr
The Lancet (British edition), 2011, Vol.378 (9786), p.156-167
7.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014, Vol.57 (12), p.2465-2474
8.
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
by Ray, Kausik K, Dr
The Lancet (British edition), 2009, Vol.373 (9677), p.1765-1772
9.
Effect of intensive glucose lowering treatment on all cause mortality cardiovascular death and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trial...
by Boussageon, R.
British medical journal, 2011, Vol.343, p.1-12
10.
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by Welsh, Paul
Diabetologia, 2018, Vol.61 (7), p.1581-1591
11.
12.
Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium
by Chen, Yu
Diabetologia, 2017, Vol.60 (6), p.1022-1032
13.
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study
by Li, Guangwei, Prof
The Lancet (British edition), 2008, Vol.371 (9626), p.1783-1789
14.
Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure
by Chen, Guanmin
Hypertension (Dallas, Tex. 1979), 2011, Vol.57 (5), p.891-897
15.
16.
Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial
by Simmons, Rebecca K, PhD
The Lancet (British edition), 2012, Vol.380 (9855), p.1741-1748
17.
Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients
by Eeg-Olofsson, K
Diabetologia, 2008, Vol.52 (1), p.65-73
18.
Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population
by van Waateringe, Robert P
Diabetologia, 2019, Vol.62 (2), p.269-280
19.
Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013
by Read, Stephanie H
Diabetologia, 2016, Vol.59 (10), p.2106-2113
20.
Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study
by Currie, Craig J
The Lancet (British edition), 2010, Vol.375 (9713), p.481-489
Filter electronic articles 1.122 Hits
Remove Filters
